These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 33854614)

  • 41. Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target.
    Nakamura K; Sawada K; Kobayashi M; Miyamoto M; Shimizu A; Yamamoto M; Kinose Y; Kimura T
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31405096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exosomal microRNAs as a potential therapeutic strategy in hepatocellular carcinoma.
    Gougelet A
    World J Hepatol; 2018 Nov; 10(11):785-789. PubMed ID: 30533178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma.
    Wang F; Li L; Piontek K; Sakaguchi M; Selaru FM
    Hepatology; 2018 Mar; 67(3):940-954. PubMed ID: 29023935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The utility of serum exosomal microRNAs in hepatocellular carcinoma.
    Jun L; Yang G; Zhisu L
    Biomed Pharmacother; 2019 Mar; 111():1221-1227. PubMed ID: 30841435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exosomes and cancer immunotherapy: A review of recent cancer research.
    Cao Y; Xu P; Shen Y; Wu W; Chen M; Wang F; Zhu Y; Yan F; Gu W; Lin Y
    Front Oncol; 2022; 12():1118101. PubMed ID: 36727049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of exosomes in hepatocellular carcinoma cell mobility alteration.
    Wang S; Chen G; Lin X; Xing X; Cai Z; Liu X; Liu J
    Oncol Lett; 2017 Dec; 14(6):8122-8131. PubMed ID: 29250190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma.
    Shen J; Huang CK; Yu H; Shen B; Zhang Y; Liang Y; Li Z; Feng X; Zhao J; Duan L; Cai X
    J Cell Mol Med; 2017 May; 21(5):986-992. PubMed ID: 28224705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatocellular carcinoma-derived exosomes in organotropic metastasis, recurrence and early diagnosis application.
    Ge Y; Mu W; Ba Q; Li J; Jiang Y; Xia Q; Wang H
    Cancer Lett; 2020 May; 477():41-48. PubMed ID: 32112905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exosomes in hepatocellular carcinoma: a new horizon.
    Chen R; Xu X; Tao Y; Qian Z; Yu Y
    Cell Commun Signal; 2019 Jan; 17(1):1. PubMed ID: 30616541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating plasma exosomal miRNA profiles serve as potential metastasis-related biomarkers for hepatocellular carcinoma.
    Huang C; Tang S; Shen D; Li X; Liang L; Ding Y; Xu B
    Oncol Lett; 2021 Feb; 21(2):168. PubMed ID: 33552286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-125a/b inhibits tumor-associated macrophages mediated in cancer stem cells of hepatocellular carcinoma by targeting CD90.
    Wang Y; Wang B; Xiao S; Li Y; Chen Q
    J Cell Biochem; 2019 Mar; 120(3):3046-3055. PubMed ID: 30536969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
    Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
    World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment.
    Sun Z; Yang S; Zhou Q; Wang G; Song J; Li Z; Zhang Z; Xu J; Xia K; Chang Y; Liu J; Yuan W
    Mol Cancer; 2018 Apr; 17(1):82. PubMed ID: 29678180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exosomes released by hepatocarcinoma cells endow adipocytes with tumor-promoting properties.
    Wang S; Xu M; Li X; Su X; Xiao X; Keating A; Zhao RC
    J Hematol Oncol; 2018 Jun; 11(1):82. PubMed ID: 29898759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-365 (microRNA): Potential Biomarker in Oral Squamous Cell Carcinoma Exosomes and Extracellular Vesicles.
    Coon J; Kingsley K; Howard KM
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32727045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intercellular communication in the tumour microecosystem: Mediators and therapeutic approaches for hepatocellular carcinoma.
    Wang WT; Jin WL; Li X
    Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166528. PubMed ID: 36007784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor-associated Exosomes Are Involved in Hepatocellular Carcinoma Tumorigenesis, Diagnosis, and Treatment.
    Wang H; Yu L; Huang P; Zhou Y; Zheng W; Meng N; He R; Xu Y; Keong TS; Cui Y
    J Clin Transl Hepatol; 2022 Jun; 10(3):496-508. PubMed ID: 35836772
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [EXOSOMES AS MEDIATORS OF INTERCELLULAR COMMUNICATION: THE CANCER AND TELOMERASE CONNECTION].
    Uziel O; Gutkin A; Beery E; Lahav M
    Harefuah; 2017 Nov; 156(11):710-714. PubMed ID: 29198089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exosome-Derived LncRNAs in Lung Cancer.
    Fan T; Sun N; He J
    Front Oncol; 2020; 10():1728. PubMed ID: 33072553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy.
    Xie F; Zhou X; Fang M; Li H; Su P; Tu Y; Zhang L; Zhou F
    Adv Sci (Weinh); 2019 Dec; 6(24):1901779. PubMed ID: 31871860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.